In the present study, we evaluated the protective effects of the TSPO ligand PK 11195 in non-neuronal (lung cancer cell line) and brain (microglial cell line) cells exposed to the hypoxic agent CoCl2 [17] in an attempt to identify the cellular mechanisms that are involved in such putative beneficial effects in peripheral and brain cells. This evidence concerns the gene TSPO and lung carcinoma.